Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPHERE: Phosphocreatine in MET-treated patients
NCT06503016Phase 3Recruiting
- Sponsor
- Vita-Salute San Raffaele University
- Start
- Oct 2024
- Primary completion
- Apr 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of phosphocreatine in heart failure (HF), cardiac arrest (SCA), sponsored by Vita-Salute San Raffaele University. Started Oct 2024; status: recruiting.
02
Drugs
phosphocreatine
03
Conditions
heart failure (HF)cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT06503016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06503016.